Ana Ayestarán

Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia

Ana Ayestarán, Rosa María López, A Estíbalez et al. · Antimicrobial Agents and Chemotherapy · 1996 · 56 citations · Full text

Pharmaceutical Science, Elimination Phase, Bioanalysis +9

Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short‐term outcome

Andrés Herrán, M.L. Ramírez, Ana Ayestarán et al. · Acta Psychiatrica Scandinavica · 2006 · 40 citations

Quality of life in early phases of panic disorder: Predictive factors

Andrés Herrán, José Luís Ayuso‐Mateos, D. Sierra‐Biddle et al. · Journal of Affective Disorders · 2006 · 37 citations

Experimental Psychopathology, Quality Of Life, Psychological Co-morbidities +12

Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study

Yolanda Meije, Alejandra Duarte-Borges, X. Sanz et al. · Clinical Microbiology and Infection · 2021 · 32 citations · Full text

Coronavirus Disease 2019, Hospitalization, Long Covid +10

Administration of Lipid-Emulsion Versus Conventional Amphotericin B in Patients with Neutropenia

Begoña Pascual, Ana Ayestarán, José Bruno Montoro Ronsano et al. · Annals of Pharmacotherapy · 1995 · 27 citations